Title Page
Contents
ABSTRACT 8
1. Introduction 10
2. Materials and methods 12
2.1. Study design 12
2.2. Inclusion and exclusion criteria 13
2.3. Physical examination 13
2.4. CBC and serum chemistry profile 14
2.5. PBMC proliferation quality evaluation 15
2.6. Reactive oxygen test 16
2.7. Anti-oxidant test 17
2.8. Feline IgG test 18
2.9. Cytokine assay 19
2.10. Statistical analysis 20
3. Results 21
3.1. Characteristics of the study population 21
3.2. CBC and serum chemistry profile 23
3.3. PBMC Relative proliferation rate 27
3.4. Results of cytokine, MDA and SOD 31
3.5. Evaluation of clinical signs 34
4. Discussion 36
5. Conclusion 40
References 41
Abstract (in Korean) 43
Table 1. Characteristics of this study population 22
Table 2. Results of hematologic parameters in 15 cats following administration of Red Ginseng Extracts 24
Table 3. Results of serum chemistry in 15 cats following the administration of Red Ginseng Extracts 25
Table 4. Results of serum chemistry in 15 cats following the administration of Red Ginseng Extracts (to be continued) 26
Table 5. PBMC Relative proliferation rate in 15 cats following administration of Red Ginseng Extracts 30
Table 6. Results of ELISA in 15 cats following the administration of Red Ginseng Extracts 32
Table 7. Results of ELISA in 15 cats following the administration of Red Ginseng Extracts 33
Table 8. Evaluation of clinical signs in 15 cats following the administration of Red Ginseng Extracts 35
Figure 1. PBMC Relative proliferation rate. Dot: Corresponding value for each object. All results of figure were expressed as mean ± standard deviation. Relative... 28
Figure 2. PBMC Relative proliferation rate bar graph. Bar: Average for each group. Relative proliferation rate = each sample OD/No Tx OD value. Statistically signific... 29